"During the study period, there were 232,268 SARS-CoV-2 infections, 7,694 COVID-19 hospitalizations, 4,481 cases of severe or critical hospitalization, and 1,113 deaths from the disease.
After adjustment for age, sex, and calendar week, the efficacy of complete BNT162b2 vaccination was 95∙3% against SARS-CoV-2 infection overall; 91∙5% against asymptomatic infection, 97∙0% against symptomatic COVID-19, 97∙2% against hospitalization, 97∙5% against severe or critical hospitalization, and 96∙7% against death from the disease.
The estimates of vaccine efficacy against all SARS-CoV-2 outcomes were higher than 96% among people aged 75 years and older."
[^] # Re: quelques commentaires
Posté par pasBill pasGates . En réponse au journal Petite question sur l'immunité collective. Évalué à 9.
Faut vraiment être stupide pour ne pas arriver à voir le succès énorme des vaccins dans les pays hautement vaccinés comme Israel par exemple.
La réalité est incontournable, elle fait juste mal aux yeux des gens ayant une peur irrationelle de la science qui préfèrent fermer les yeux.
https://www.news-medical.net/news/20210506/Israeli-study-shows-real-world-efficacy-of-Pfizer-BioNTeche28099s-COVID-19-vaccine.aspx
"During the study period, there were 232,268 SARS-CoV-2 infections, 7,694 COVID-19 hospitalizations, 4,481 cases of severe or critical hospitalization, and 1,113 deaths from the disease.
After adjustment for age, sex, and calendar week, the efficacy of complete BNT162b2 vaccination was 95∙3% against SARS-CoV-2 infection overall; 91∙5% against asymptomatic infection, 97∙0% against symptomatic COVID-19, 97∙2% against hospitalization, 97∙5% against severe or critical hospitalization, and 96∙7% against death from the disease.
The estimates of vaccine efficacy against all SARS-CoV-2 outcomes were higher than 96% among people aged 75 years and older."